Regulating “Higher Risk, No Direct Benefit” Studies in Minors
Author:
Publisher
Informa UK Limited
Subject
Health Policy,Issues, ethics and legal aspects
Link
http://www.tandfonline.com/doi/pdf/10.1080/15265161.2011.566669
Reference9 articles.
1. Stimulation programs for pediatric drug research – do children really benefit?
2. Knowledge of developmental pharmacology and modeling approaches should be used to avoid useless trials in children
3. What Makes Clinical Research Ethical?
4. Minimal Risk as an International Ethical Standard in Research
5. The Enforcement of Morals: Nontherapeutic Research on Children
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Anything Goes? Analyzing Varied Understandings of Assent;Cambridge Quarterly of Healthcare Ethics;2022-12-05
2. Ethical Issues for Children With Cancer;Ethical Challenges in Oncology;2017
3. Ambiguous articles in new EU Regulation may lead to exploitation of vulnerable research subjects;Journal of Medical Ethics;2016-01-04
4. Pharmacogenetics of taste: turning bitter pills sweet?;Pharmacogenomics;2014-01
5. Improving the Helsinki Declaration's guidance on research in incompetent subjects;Journal of Medical Ethics;2013-09-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3